Xiaodong Guo

2.9k total citations
89 papers, 2.2k citations indexed

About

Xiaodong Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaodong Guo has authored 89 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 23 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Xiaodong Guo's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (10 papers). Xiaodong Guo is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (10 papers). Xiaodong Guo collaborates with scholars based in China, United States and Singapore. Xiaodong Guo's co-authors include Lu Xiong, Mei Yang, Zhiwei Li, Yanqiong Zhang, Lingxiang Yu, Lin Zou, Na Lin, Jingmin Zhao, Jingmin Zhao and Hanwei Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xiaodong Guo

85 papers receiving 2.2k citations

Peers

Countries citing papers authored by Xiaodong Guo

Since Specialization

Citations

This map shows the geographic impact of Xiaodong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Guo more than expected).

Fields of papers citing papers by Xiaodong Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Guo. The network helps show where Xiaodong Guo may publish in the future.

Co-authorship network of co-authors of Xiaodong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Guo. A scholar is included among the top collaborators of Xiaodong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Guo. Xiaodong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention 2024 ·Clinica Chimica Acta ·Xiaodong Guo, (unknown), (unknown), Zhongxiao Zhang, Jingxia Wang, Xuan Liu	8
2	A dual encoder LDCT image denoising model based on cross-scale skip connections 2024 ·Neurocomputing ·Lifang Wang, Yali Wang, Wenjing Ren, (unknown), (unknown), Xiaodong Guo, Lihua Hu	4
3	Harmful evaluation of heavy metals from soil layer to the groundwater: Take the Jilin Hunchun Basin as an example 2023 ·China Geology ·Xiaodong Guo, Qiang Liu, Huirong Zhang, (unknown), Chuanyu Qin, Zhiqiang Zhang	3
4	Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles 2022 ·Journal of Cachexia Sarcopenia and Muscle ·Meng Fan, Xiaofan Gu, Wanli Zhang, Qiang Shen, (unknown), (unknown), (unknown), Xiaodong Guo, Xiongwen Zhang, Xuan Liu	37
5	Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation 2022 ·Experimental & Molecular Medicine ·(unknown), Zhaochen Ma, Lingxiang Yu, Xia Mao, Nan Ma, Xiaodong Guo, Xiaoli Yin, Funeng Jiang, Qian Wang, Jigang Wang, Mingliang Fang, (unknown), Yanqiong Zhang	28
6	Bone marrow mesenchymal stem cell exosomes suppress phosphate-induced aortic calcification via SIRT6–HMGB1 deacetylation 2021 ·Stem Cell Research & Therapy ·(unknown), Xiaodong Guo, (unknown), Jieshuang Jia, Man Yang, Weijie Yuan, Rong Shu	38
7	Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies 2019 ·World Journal of Pediatrics ·(unknown), (unknown), Qiang Shu, Xiaodong Guo	34
8	Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I 2019 ·Acta Pharmacologica Sinica ·Wanli Zhang, Na Li, Qiang Shen, (unknown), Xiaodong Guo, Xiongwen Zhang, Zhou Zhang, Xuan Liu	25
9	CHRNA5/CHRNA3 gene cluster is a risk factor for lumbar disc herniation: a case-control study 2019 ·Journal of Orthopaedic Surgery and Research ·(unknown), Xiaodong Guo, Zhi Huang, (unknown), Wenhua Xing, Feng Li, (unknown), Ke Sun, (unknown), (unknown)	8
10	FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells 2018 ·Cellular Physiology and Biochemistry ·Zhuo Gao, Ruiqi Liu, Na Ye, Chao Liu, Xiuli Li, Xiaodong Guo, Zhuoran Zhang, Xiaoxi Li, Yuanfei Yao, Xiaofeng Jiang	27
11	In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma 2017 ·Medicine ·(unknown), Jianxiang Liu, (unknown), Feifei Pu, (unknown), Qiang Wu, Yukun Zhang, (unknown), Xiaodong Guo, Shuhua Yang, Tong‐Chuan He	26
12	Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis 2015 ·PLoS ONE ·Mei Yang, Dongping Xu, Yuan Liu, Xiaodong Guo, Wenshu Li, (unknown), (unknown), Yinjie Gao, Yuanli Mao, Jingmin Zhao	60
13	Clinical study of raltitrexed combined with cisplatin for the double-channel chemotherapy in the treatment of patients with advanced colorectal cancer 2014 ·Jie Chen, (unknown), (unknown), (unknown), Weiwei Zhang, Xiaodong Guo, (unknown)	0
14	Hepatic Angiomyolipoma Mimicking Hepatocellular Carcinoma 2014 ·Medicine ·Chunping Wang, (unknown), Hong Wang, Xiaodong Guo, Changchun Liu, Shuhong Liu, Xudong Gao, Jianhui Qu, Ze Liu, Xiujuan Chang, Yinying Lu, (unknown), Min Lou, Yongping Yang	20
15	Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation 2013 ·Molecular BioSystems ·Yanqiong Zhang, Xiaodong Guo, Mei Yang, Lingxiang Yu, Zhiwei Li, Na Lin	19
16	Expression and Clinical Significance of Beclin 1 in Patients with Hepatocellular Carcinoma 2013 ·Xiandai shengwu yixue jinzhan ·Xiaodong Guo, (unknown), (unknown), Ruisheng Li, (unknown), (unknown), (unknown), Jin Li	2
17	RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling 2012 ·Neuro-Oncology ·Bei Liu, Liang Wang, Liangliang Shen, Mingzhi Shen, Xiaodong Guo, (unknown), Qinchuan Liang, Chao Wang, Jun Zheng, Yi Li, Lintao Jia, Hua Zhang, Guodong Gao	26
18	Calcium overload and reactive oxygen species mediate high glucose-induced apoptosis of mouse osteoblast MC3T3-E1 cells 2012 ·Zhongguo bingli shengli zazhi ·Xiaodong Guo	1
19	Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis 2011 ·Scandinavian Journal of Gastroenterology ·Jingmin Zhao, Suxian Zhao, Guangde Zhou, Liang Li, Xiaodong Guo, Panyong Mao, (unknown), Haibin Wang, Yuemin Nan, Dongping Xu, Jun Yu	37
20	First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study 2009 ·Journal of Thoracic Oncology ·(unknown), Weiguo Cao, (unknown), (unknown), Xiaodong Guo, Guang Huang, Lijun Ma, (unknown), Chunfang Gao, Bao‐Liang Zhong, (unknown), Steven Tucker, Daoyuan Wang	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact